Project Grant R01GM155563
Award Date
8/1/24
Completion Date
5/31/28
Dollars Obligated
$940K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Tempe, AZ 85287, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $202,274 to develop an easy-to-use computer program for predicting the structure and degrading efficiency of proteolysis targeting chimeras (PROTACs). PROTACs are heterobifunctional molecules that induce the degradation of target proteins by recruiting them to E3 ubiquitin ligases. The awarded project aims to implement a...
This Project Grant award of $388,621 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support the development of novel molecular designs with therapeutic potential. The key objectives are: Developing ligand-heterocycle conjugates as targeted RNA degraders with rapid kinetics and selectivity for cancer-associated G-quadruplexes. Engineering nucleic acid polymers with (thio)phosphoramidate backbones as biostable...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,044,566 to Arizona State University (ASU) to develop machine learning models for studying protein interactions in the context of immune receptors. The key goals are: 1) creating effective embeddings of biological sequences to design protein language models, and 2) applying these embeddings to generate novel T-cell receptors (TCRs)...
This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), is focused on developing programmable, isoform-selective tools for proteome editing. Key goals of the research include: Enabling peptide-guided deubiquitination to provide "on" and "off" switches for controlling protein states in cells. Leveraging protein language models to design binders that selectively...
This Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) seeks to optimize the structure and amphiphilicity of Peptide-based Proteolysis Targeting Chimeras (PepTACs) to enhance their ability to induce targeted protein degradation through the ubiquitin-proteasome pathway. The $316,226 award will fund a 4-year research project to explore structural modifications to PepTACs that can improve...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,203,701 to The Research Foundation For The State University Of New York to conduct research aimed at improving drug development processes. The key focus areas include: Selectively targeting the inactive state of human protein kinases to rapidly identify promising new drug targets, including through the use of novel ATP-allosteric...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of engineered enzymes that can be activated to perform targeted modifications of cellular proteins. The $1,602,000 award to the Dana-Farber Cancer Institute, Inc. (DFCI) will fund research to design and apply novel autoinhibited enzymes that can toggle between inactive and active conformations in response...
This federal Project Grant award, provided by the National Science Foundation (NSF) under the Mathematical and Physical Sciences (CFDA 47.049) program, supports the development of experimental and theoretical frameworks for optimizing targeted protein degrader compounds. The $492,000 award, spanning July 2024 to June 2029, allows Professor Ferguson at the University of California, San Diego to evaluate the kinetic parameters of targeted protein degradation across the kinome and develop new...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of novel molecular technologies for targeted protein degradation. Specifically, the $299,978 award to Lifesensors Inc., a biotechnology company in Malvern, PA, will fund research on "molecular glue degraders" - small molecules that can induce proximity between target proteins and E3...
The Arizona State University was awarded a $2,678,944 Project Grant from the Department of Health and Human Services Assistant Secretary for Financial Resources' Biomedical Research and Research Training program (CFDA 93.859) to develop an integrated nano-opto-fluidic system on sapphire for single-molecule protein sequencing from September 1, 2022 to August 31, 2025. The University will design an on-chip electronic system incorporating nano-opto-fluidic structures to transduce protein...